An investigation of Selank’s immunomodulatory actions on interleukin-6 and TNF-alpha gene expression in splenic macrophage assays.

An in-depth, systems-level preclinical research synthesis of Semax’s regulation of BDNF and TrkB tyrosine kinase activation in hippocampal cultures.

An analytical research synthesis of Semax-mediated regulation of BDNF and TrkB tyrosine kinase activation in hippocampal neuronal cultures.

Neurotrophic Transcription: Semax Regulation of BDNF and TrkB Tyrosine Kinase Activation in Hippocampal Cultures

← Back to The Cognitive Edge Neurotrophic Transcription: Semax Regulation of BDNF and TrkB Tyrosine Kinase Activation in Hippocampal Cultures Section 1: Compound Overview Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide derived from the adrenocorticotropin fragment ACTH(4–10). The parent sequence, shared across several melanocortin analogs, lacks adrenocorticotropic hormonal activity but retains significant central nervous system bioactivity. […]

Semax is a synthetic heptapeptide analog derived from the adrenocorticotropic hormone fragment ACTH(4-10), with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro.

This analysis reviews rodent-model literature on Semax and the upregulation of BDNF and NGF expression without direct TrkB receptor binding.

A review of Selank’s impact on interleukin expression and immune signaling in laboratory splenocyte models.

Dissecting Semax’s central melanocortin receptor MC4R binding mechanisms and its downstream neurotrophic effects via the BDNF-TrkB transcription pathway.

Investigating the hippocampal versus cortical expression kinetics of NGF and BDNF alongside positive allosteric modulation of AMPA receptors by Noopept.

An exploration of the ACTH(4-10) analog Semax, focusing on TrkB receptor phosphorylation kinetics and transcriptomic upregulation of BDNF.